Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Osteoporosis
Interventions: DIETARY_SUPPLEMENT: calcium carbonate|DIETARY_SUPPLEMENT: vitamin D|DRUG: risedronate sodium|OTHER: placebo
Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)